Antipodean Pharmaceuticals, Inc.
Antipodean Pharmaceuticals initiates phase II trial in Parkinson disease
Published in Mental Health Law Weekly, June 24th, 2006
The trial will be led by Barry Snow, MD, FRACP, FRCP, head of the Department of Neurology, Auckland Hospital and involve 10 consultant neurologists at the country's main regional hospitals who will assess and advise potential participants. Parkinsons New Zealand, a non-profit patient information and support group will also be involved to help patients.
"This is potentially groundbreaking technology," said Michael Murphy, PhD, MRC, Dunn Human Nutrition...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Law Weekly
More Articles from Mental Health Law Weekly
- ExonHit Therapeutics
ExonHit files patent on a panel of genes for the diagnosis of Alzheimer disease from blood - Free University of Amsterdam
Free University of Amsterdam researchers describe recent findings - Gedeon Richter Chemical Works
Alzheimer disease drug candidates can be screened using a flow cytometry method - Migenix Corp.
Alzheimer disease etiology can be influenced by the mitochondrial genome - Sleep Study
Television viewing related to children's sleeping difficulties - St. Vincents Hospital, Darlinghurst
Aberrant NPY, MIC-1 expression are associated with poor prognosis in prostate cancer - More from this issue of Mental Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
